|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
children
|
|
gptkbp:alternativeTo
|
gptkb:Tdap
gptkb:DTwP
|
|
gptkbp:approvedBy
|
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:broadcastOn
|
5 doses in childhood
|
|
gptkbp:compatibleWith
|
adolescents
adults
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
encephalopathy after previous dose
|
|
gptkbp:fifthDoseAge
|
4-6 years
|
|
gptkbp:firstDoseAge
|
2 months
|
|
gptkbp:fourthDoseAge
|
15-18 months
|
|
gptkbp:hasComponent
|
acellular pertussis
diphtheria toxoid
tetanus toxoid
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DTaQ
|
|
gptkbp:protectedBy
|
diphtheria
tetanus
pertussis
|
|
gptkbp:recommendation
|
gptkb:Centers_for_Disease_Control_and_Prevention
|
|
gptkbp:replacedBy
|
gptkb:DTwP
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:secondDoseAge
|
4 months
|
|
gptkbp:sideEffect
|
fever
swelling at injection site
redness at injection site
mild fussiness
|
|
gptkbp:thirdDoseAge
|
6 months
|
|
gptkbp:usedIn
|
gptkb:Europe
gptkb:United_States
many countries worldwide
|
|
gptkbp:bfsParent
|
gptkb:국방기술품질원
|
|
gptkbp:bfsLayer
|
6
|